- Home
- CANG vs DNA Comparison
CANG vs DNA Comparison
Compare CANG & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CANG
- DNA
- Stock Information
- Founded
- CANG 2010
- DNA 2008
- Country
- CANG Hong Kong
- DNA United States
- Employees
- CANG N/A
- DNA N/A
- Industry
- CANG Computer Software: Prepackaged Software
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CANG Technology
- DNA Health Care
- Exchange
- CANG Nasdaq
- DNA Nasdaq
- Market Cap
- CANG 811.9M
- DNA 731.1M
- IPO Year
- CANG 2018
- DNA N/A
- Fundamental
- Price
- CANG $4.57
- DNA $10.26
- Analyst Decision
- CANG Strong Buy
- DNA Hold
- Analyst Count
- CANG 1
- DNA 2
- Target Price
- CANG $8.00
- DNA $9.50
- AVG Volume (30 Days)
- CANG 514.7K
- DNA 1.6M
- Earning Date
- CANG 11-03-2025
- DNA 11-11-2025
- Dividend Yield
- CANG N/A
- DNA N/A
- EPS Growth
- CANG N/A
- DNA N/A
- EPS
- CANG N/A
- DNA N/A
- Revenue
- CANG $398,195,540.00
- DNA $230,815,000.00
- Revenue This Year
- CANG $469.55
- DNA N/A
- Revenue Next Year
- CANG $18.83
- DNA $13.73
- P/E Ratio
- CANG N/A
- DNA N/A
- Revenue Growth
- CANG 380.74
- DNA 25.21
- 52 Week Low
- CANG $1.46
- DNA $5.00
- 52 Week High
- CANG $9.66
- DNA $16.85
- Technical
- Relative Strength Index (RSI)
- CANG 43.88
- DNA 40.65
- Support Level
- CANG $4.54
- DNA $9.95
- Resistance Level
- CANG $5.55
- DNA $11.97
- Average True Range (ATR)
- CANG 0.31
- DNA 0.78
- MACD
- CANG -0.03
- DNA -0.21
- Stochastic Oscillator
- CANG 11.00
- DNA 9.89
About CANG Cango Inc. each representing two (2)
Cango Inc through its subsidiaries, variable interest entities (VIEs), and subsidiaries of the VIEs, are principally engaged in the bitcoin mining business, and the automobile trading transaction, automotive financing facilitation, and aftermarket service facilitation businesses (collectively, the automobile and related businesses). The Company conducts the bitcoin mining business mainly through its subsidiaries, and the automobile and associated businesses are conducted through the Company's VIEs and the subsidiaries of the VIEs. The company derives the majority of its revenue from the bitcoin mining business.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.